Vaginal Ring Holds Potential in Preventing HIV and Pregnancy by Angela Mohan on January 27, 2021 at 3:23 PM
Vaginal ring containing Dapivirine and levonorgestrel delivered sustained levels of drugs when used continuously for 90 days, levels likely sufficient to serve dual purpose for protecting against both HIV and unwanted pregnancy.
Results of the Phase I study of the 90-day dual-purpose ring are being presented at the HIV Research for Prevention (HIVR4P) Virtual Conference, or HIVR4P Virtual, which is taking place over the course of four days.
The study, MTN-044/IPM 053/CCN019, was conducted by researchers from the National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN) in collaboration with NIH s Contraceptive Clinical Trials Network (CCTN) and is the first to evaluate the ring s use, as intended, for 90 days.